In vitro activity of a new broad-spectrum, beta-lactamase-stable oral cephalosporin, cefixime, in comparison with other drugs, against Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis and Streptococcus pneumoniae.

Antibacterial activity of cefixime against Streptococcus pneumoniae, Streptococcus pyogenes, and Haemophilus influenzae in the presence of Moraxella (Branhamella) catarrhalis.

In vitro activity of BAY v 3522, a new oral cephalosporin tested against Haemophilus influenzae and Branhamella catarrhalis.

Identification of Alloiococcus otitidis, Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae in Children With Otitis Media With Effusion.

Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States.

In vitro activity of loracarbef (LY163892), a new oral carbacephem antimicrobial agent, against respiratory isolates of Haemophilus influenzae and Moraxella catarrhalis.

Haemophilus influenzae and haemophilus parainfluenzae in chronic obstructive pulmonary disease.

In vitro activity of tosufloxacin (A-60969) and clarithromycin (A-56268, TE-031) against resistant Haemophilus influenzae, Streptococcus pneumoniae and Branhamella catarrhalis isolates.

A fluorescent multiplexed bead-based immunoassay (FMIA) for quantitation of IgG against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis protein antigens.

Comparison of the activity of cefixime and activities of other oral antibiotics against adult clinical isolates of Moraxella (Branhamella) catarrhalis containing BRO-1 and BRO-2 and Haemophilus influenzae.

In vitro activity of cefprozil (BMY 28100) and cefepime (BMY 28142) against Streptococcus pneumoniae, Branhamella catarrhalis, and Haemophilus influenzae, and provisional interpretive criteria for disk diffusion and dilution susceptibility tests with Haemophilus influenzae.

Antibacterial activity of eight cephalosporins against Haemophilus influenzae and Streptococcus pneumoniae.

New satellitism test for isolation and identification of Haemophilus influenzae and Haemophilus parainfluenzae in sputum.

Natural Development of Antibodies against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Protein Antigens during the First 13 Years of Life.

Anti-adhesive activity of human casein against Streptococcus pneumoniae and Haemophilus influenzae.

Antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae.

Antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae.

Immunoglobulin A1 protease production by Haemophilus influenzae and Streptococcus pneumoniae.

Appendicitis due to both Streptococcus pneumoniae and Haemophilus influenzae.

Methylase activities from Haemophilus influenzae that protect Haemophilus parainfluenzae transforming deoxyribonucleic acid from inactivation by Haemophilus influenzae endonuclease R.

In vitro susceptibility of Haemophilus influenzae to cefaclor, cefixime, cefetamet and loracarbef.

Copper-zinc superoxide dismutase of Haemophilus influenzae and H. parainfluenzae.

Haemophilus influenzae and H. parainfluenzae as urinary pathogens.

Occurrence of Streptococcus pneumoniae and Haemophilus influenzae in otitis media with effusion.

In vitro evaluation of nicotinamide riboside analogs against Haemophilus influenzae.

Suggest Documents

Antibacterial activity of cefixime against Streptococcus pneumoniae, Streptococcus pyogenes, and Haemophilus influenzae in the presence of Moraxella (Branhamella) catarrhalis.

In vitro activity of BAY v 3522, a new oral cephalosporin tested against Haemophilus influenzae and Branhamella catarrhalis.

Identification of Alloiococcus otitidis, Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae in Children With Otitis Media With Effusion.

Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States.

In vitro activity of loracarbef (LY163892), a new oral carbacephem antimicrobial agent, against respiratory isolates of Haemophilus influenzae and Moraxella catarrhalis.

Haemophilus influenzae and haemophilus parainfluenzae in chronic obstructive pulmonary disease.

In vitro activity of tosufloxacin (A-60969) and clarithromycin (A-56268, TE-031) against resistant Haemophilus influenzae, Streptococcus pneumoniae and Branhamella catarrhalis isolates.

A fluorescent multiplexed bead-based immunoassay (FMIA) for quantitation of IgG against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis protein antigens.

Comparison of the activity of cefixime and activities of other oral antibiotics against adult clinical isolates of Moraxella (Branhamella) catarrhalis containing BRO-1 and BRO-2 and Haemophilus influenzae.

In vitro activity of cefprozil (BMY 28100) and cefepime (BMY 28142) against Streptococcus pneumoniae, Branhamella catarrhalis, and Haemophilus influenzae, and provisional interpretive criteria for disk diffusion and dilution susceptibility tests with Haemophilus influenzae.

Antibacterial activity of eight cephalosporins against Haemophilus influenzae and Streptococcus pneumoniae.

New satellitism test for isolation and identification of Haemophilus influenzae and Haemophilus parainfluenzae in sputum.

Natural Development of Antibodies against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Protein Antigens during the First 13 Years of Life.

Anti-adhesive activity of human casein against Streptococcus pneumoniae and Haemophilus influenzae.

Antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae.

Antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae.

Immunoglobulin A1 protease production by Haemophilus influenzae and Streptococcus pneumoniae.

Appendicitis due to both Streptococcus pneumoniae and Haemophilus influenzae.

Methylase activities from Haemophilus influenzae that protect Haemophilus parainfluenzae transforming deoxyribonucleic acid from inactivation by Haemophilus influenzae endonuclease R.

In vitro susceptibility of Haemophilus influenzae to cefaclor, cefixime, cefetamet and loracarbef.

Copper-zinc superoxide dismutase of Haemophilus influenzae and H. parainfluenzae.

Haemophilus influenzae and H. parainfluenzae as urinary pathogens.

Occurrence of Streptococcus pneumoniae and Haemophilus influenzae in otitis media with effusion.

In vitro evaluation of nicotinamide riboside analogs against Haemophilus influenzae.

In vitro activity of a new broad-spectrum, beta-lactamase-stable oral cephalosporin, cefixime, in comparison with other drugs, against Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis and Streptococcus pneumoniae.

Recommend Documents

Follow Us